<DOC>
	<DOCNO>NCT01988311</DOCNO>
	<brief_summary>This pilot study finalize method large study plan future . This research do characterize performance task , brain functioning , effect psilocybin individual long-term meditation practice . There three different part pilot study : 1 . Effects psilocybin psychological function : This version pilot study involve 1 2 day-long psilocybin session , several meeting data assessment visit . You make total 5 10 visit research unit ( BPRU Johns Hopkins Bayview Campus ) . 2 . Performance behavioral cognitive task : This version pilot study involve complete various behavioral cognitive task research unit . You make total 1-10 visit research unit ( BPRU Johns Hopkins Bayview Campus ) . 3 . Brain functioning : This version study involve 1 3 brain imaging ( MRI ) measurement . You make total 2 5 visit research unit ( BPRU Johns Hopkins Bayview Campus ) . The MRI measurement take F.M . Kirby Research Center Kennedy Krieger Institute ( across street Johns Hopkins Hospital ) . People age 25 80 year old , current , regular meditation practice , meet medical requirement may join .</brief_summary>
	<brief_title>Pilot Study : Effects Psilocybin Behavior , Psychology Brain Function Long-term Meditators</brief_title>
	<detailed_description />
	<mesh_term>Psilocybine</mesh_term>
	<criteria>25 80 year old Have give write informed consent Have collegelevel education ( college degree prefer ) Be healthy psychologically stable determine screen medical psychiatric problem via personal interview , medical questionnaire , physical examination , electrocardiogram ( ECG ) , routine medical blood urinalysis laboratory test Agree consume approximately amount caffeinecontaining beverage ( e.g. , coffee , tea ) he/she consume usual morning , arrive research unit morning drug session day . If participant routinely consume caffeinated beverage , he/she must agree session day . Agree refrain use psychoactive drug , include alcoholic beverage nicotine , within 24 hour drug administration . The exception caffeine . Participants require nonsmoker . Agree take PRN medication morning drug session Agree take sildenafil ( ViagraÂ® ) , tadalafil , similar medication within 72 hour drug administration . Agree one week drug session , he/she refrain take nonprescription medication , nutritional supplement , herbal supplement except approve study investigator . Exceptions evaluate study investigator include acetaminophen , nonsteroidal antiinflammatory drug , common dos vitamin mineral . Women pregnant ( indicated positive urine pregnancy test assess intake drug session ) nursing ; woman childbearing potential sexually active practice effective mean birth control . Cardiovascular condition : coronary artery disease , stroke , angina , uncontrolled hypertension , clinically significant ECG abnormality ( e.g. , atrial fibrillation ) , TIA past year Epilepsy history seizure Insulindependent diabetes ; take oral hypoglycemic agent , history hypoglycemia Currently take psychoactive prescription medication regular ( e.g. , daily ) basis Currently take regular ( e.g. , daily ) basis medication primary centrallyacting pharmacological effect serotonin neuron medication MAO inhibitor . For individual intermittent PRN use medication , psilocybin session conduct least 5 halflives agent elapse last dose . More 20 % outside upper low range ideal body weight accord Metropolitan Life height weight table Psychiatric Current past history meeting DSMIV criterion Schizophrenia , Psychotic Disorder ( unless substanceinduced due medical condition ) , Bipolar I II Disorder Current past history within last 5 year meet DSMIV criterion alcohol drug dependence ( exclude caffeine nicotine ) severe major depression Have first seconddegree relative Schizophrenia , Psychotic Disorder ( unless substance induce due medical condition ) , Bipolar I II Disorder Has psychiatric condition judge incompatible establishment rapport safe exposure psilocybin fMRI Head trauma Claustrophobia Cardiac pacemaker Implanted cardiac defibrillator Aneurysm brain clip Inner ear implant Artificial heart valve ( last 6 week ) Prior history metal worker and/or certain metallic object body</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Psilocybin</keyword>
	<keyword>Hallucinogens</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Central Nervous System Agents</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Psychotropic Drugs</keyword>
</DOC>